Glenmark Pharmaceuticals Ltd. secured the U.S. Food and Drug Administration approval to market a generic version of Benicar.

Benicar is Daiichi Sankyo Co. Ltd.'s hypertension drug, and Glenmark will manufacture it at its facility in Goa, India.

Benicar generated $950 million in sales during the 12 months ending March, according to IMS Health data.